News

Gazing at the iconic 19th-century Japanese woodcut known as “The Great Wave off Kanagawa,” one would hardly suspect it contains a key to a medical breakthrough. Yet the pigment in the artwork has opened a new perspective in the treatment of juvenile cancer.

Innumerable questions and concerns loom after a cancer diagnosis. Among them: Should I participate in a clinical trial, or should I stick with the standard of care? Here's an inside look at the clinical trials process.

A research team led by Catherine Bollard, PhD, associate center director for translational research and innovation, has developed a new therapeutic cancer treatment called TAA-T.

In June 2018, before a room full of oncology experts, Robert Siegel, MD ’77, associate center director for education, training, and network development at the GW Cancer Center, described a new treatment developed for patients suffering from oropharyngeal cancer.

The future of cancer research, in the opinion of Katherine Chiappinelli, PhD, of the GW School of Medicine and Health Sciences, revolves around combining immunotherapy with other treatments.

The George Washington University (GW) Cancer Center was pleased to participate in the 43rd Annual Marine Corps Marathon (MCM) on October 28, 2018. The event is one of the largest in the world with over 30,000 participants and brings together multiple organizations to raise funds for charitable...

Applications for the second cohort of the Together, Equitable, Accessible, Meaningful (TEAM) Training are now open! This no-cost training aims to support equitable, accessible and patient-centered cancer care. The training provides guidance, tools and resources to help individuals and organizations...

WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the...

Associate Professor at the Milken Institute School of Public Health at GW and GW Cancer Center member Kim Robien, PhD, RD, CSO, FAND, received the Distinguished Practice Award from the Oncology Nutrition practice group of the Academy of Nutrition and Dietetics on October 21st at the annual Food and...

A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct. 17 to cut the ribbon on a new multi-disciplinary cancer clinical space in the ground floor of the GW Medical Faculty Associates (GW MFA) Ambulatory Care...

More people in the United States die from lung cancer than any other type of cancer (Centers for Disease Control and Prevention (CDC), 2018). Lung Cancer Awareness Month in November is an annual opportunity to support lung cancer survivors, caregivers and families of those who have been diagnosed...

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.

Did you know that breast cancer in the United States is the most common cancer in women, except for skin cancers (CDC, 2018)? October is Breast Cancer Awareness Month, an important time to honor and support the 3.1 million breast cancer survivors in the United States (American Cancer Society, 2018...

WASHINGTON (Sept. 26, 2018) – Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences. He will also serve as a professor in the department. "As an internationally recognized researcher...

Dr. Adam Friedman joins breast cancer survivor Mariam Said to discuss side effects of cancer treatment and how the Supportive Oncodermatology Clinic at the GW Cancer Center is giving patients hope and resources for relief.

The George Washington University (GW) Cancer Center recently co-hosted a workshop on Improving the Health of the LGBTQ+ Community: Advocating for Ourselves Together at Metropolitan Community Church in D.C. More than 60 researchers, students, community members and health care workers gathered to...

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.

A study led by Paul Brindley, PhD, is looking at the cellular link between liver fluke and cholangiocarcinoma.

Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.

A team at the GW Cancer Center will study the role of the COMPASS complex in the initiation and progression of pancreatic cancer.

September is Prostate Cancer Awareness Month, also known as National Prostate Health Month, an annual opportunity to raise awareness of the disease and identify funding resources for research into its cause, prevention, diagnosis, treatment, survivorship and cure as well as to support those...

WASHINGTON (July 27, 2018) -- The George Washington University Hospital (GW Hospital), in conjunction with The GW Cancer Center, has been named a Screening Center of Excellence by the Lung Cancer Alliance (LCA) for its ongoing commitment to responsible lung cancer screening. GW Hospital is one of...

Steven A. Rosenberg, MD, received the 2018 Jacobson Innovation Award from the American College of Surgeons for his work in immunotherapies for patients with advanced cancer.

Advances in cancer genetic testing have improved clinical follow-up care for patients at risk for hereditary cancer. However, they have also highlighted the important role that cancer genetic specialists can play in conjunction with primary care providers, like obstetricians and gynecologists, as...

The GW School of Medicine and Health Sciences, in partnership with the GW Cancer Center, has launched a new summer program to advance cancer research through enhancing diversity in the field.